Pediatric cardiology unit, CHU de Nantes, 38, boulevard Jean-Monnet, 44093 Nantes cedex, France.
Arch Cardiovasc Dis. 2011 Nov;104(11):578-85. doi: 10.1016/j.acvd.2010.06.006. Epub 2010 Sep 21.
Over the last three decades, knowledge about fundamental and clinical aspects of the ductus arteriosus has substantially improved, leading to considerable progress in the management of various cardiac diseases involving the ductus. The identification of the mechanisms regulating ductal patency led to design pharmacological drugs to achieve medical closure of PDA in premature infants, or inversely to maintain patency in neonates with duct-dependent congenital heart diseases. Concurrently, widespread availability of echocardiography has improved the detection of congenital PDA, resulting in earlier treatment. Closure of PDA, by either surgery or transcatheter techniques, can now be achieved safely, resulting in a decrease in the incidence of severe complications of PDA.
在过去的三十年中,人们对动脉导管的基础和临床方面的了解有了实质性的提高,这使得涉及动脉导管的各种心脏疾病的治疗取得了相当大的进展。对调节导管通畅性的机制的识别,导致了设计药理学药物以实现早产儿的动脉导管未闭的医学闭合,或者相反,维持依赖导管的先天性心脏病新生儿的导管通畅性。同时,超声心动图的广泛应用提高了先天性动脉导管未闭的检出率,从而实现了更早的治疗。现在可以通过手术或经导管技术安全地闭合动脉导管未闭,从而降低动脉导管未闭严重并发症的发生率。